Abstract: The present invention discloses an ophthalmic formulation/composition comprising cinnamic acids or their derivatives catechins or its derivatives either alone or in combination thereof together with acceptable excipients for treating/clearing/reducing conditions associated with cataract intraocular pressure and glaucoma lenticular degeneration corneal epithelial proliferation and liquefaction and inflammation.
| # | Name | Date |
|---|---|---|
| 1 | 202517046441-STATEMENT OF UNDERTAKING (FORM 3) [14-05-2025(online)].pdf | 2025-05-14 |
| 2 | 202517046441-REQUEST FOR EXAMINATION (FORM-18) [14-05-2025(online)].pdf | 2025-05-14 |
| 3 | 202517046441-FORM 18 [14-05-2025(online)].pdf | 2025-05-14 |
| 4 | 202517046441-FORM 1 [14-05-2025(online)].pdf | 2025-05-14 |
| 5 | 202517046441-DRAWINGS [14-05-2025(online)].pdf | 2025-05-14 |
| 6 | 202517046441-DECLARATION OF INVENTORSHIP (FORM 5) [14-05-2025(online)].pdf | 2025-05-14 |
| 7 | 202517046441-COMPLETE SPECIFICATION [14-05-2025(online)].pdf | 2025-05-14 |
| 8 | 202517046441-FORM-26 [17-07-2025(online)].pdf | 2025-07-17 |
| 9 | 202517046441-GPA-010825.pdf | 2025-08-05 |
| 10 | 202517046441-Correspondence-010825.pdf | 2025-08-05 |
| 11 | 202517046441-Proof of Right [30-10-2025(online)].pdf | 2025-10-30 |
| 12 | 202517046441-FORM 3 [10-11-2025(online)].pdf | 2025-11-10 |